HELX

Technical Sentiment Analysis for Franklin Genomic Advancements ETF (HELX). As of 2026-06-12, Franklin Genomic Advancements ETF (HELX) is exhibiting a Strong buy technical sentiment. Our proprietary analysis, which aggregates 10 technical signals, shows that 9 indicators are flashing buy, while 1 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status. Currently, the Relative Strength Index (RSI) for HELX stands at 57, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.43, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 76.7 and the Commodity Channel Index (CCI) at 79.63 further confirm a 0.02 outlook for the ETF.

Support, Resistance & Moving Averages. From a structural perspective, HELX is trading below its 60-day moving average of $33.76 and below its 200-day long-term moving average of $34.27. Key price levels to watch include the immediate resistance at $35.82 and strong support at $34.24. A break above $35.82 could signal a bull continuation, while falling below $34.24 may test the next Fibonacci floor at $33.41.